1887

Abstract

Summary: The resurgence of tuberculosis, the emergence of multiple drug resistant tuberculosis, and the increasing prevalence of mycobacterial disease in AIDS patients have increased the importance of defining new mycobacterial antigens that can be utilized in the development of improved diagnostic reagents and more effective vaccines. In this report, a highly immunogenic protein (MK35) and the gene encoding this antigen were characterized. MK35 gene probes reacted with genomic DNA from BCG, and but not with DNA isolated from nine other mycobacterial species. Nucleotide sequence analysis showed that the MK35 gene encodes a 26 kDa protein which contains a consensus bacterial lipoprotein processing sequence. In addition, detergent-phase separation studies strongly suggested that MK35 is a lipoprotein. Skin test assays demonstrated that MK35 elicited a strong response in guinea pigs sensitized with but did not react in -sensitized guinea pigs. These results further suggest that mycobacterial lipoproteins are immunogenic antigens that should be considered in the development of new mycobacterial vaccines and diagnostic reagents.

Loading

Article metrics loading...

/content/journal/micro/10.1099/13500872-141-10-2705
1995-10-01
2021-10-26
Loading full text...

Full text loading...

/deliver/fulltext/micro/141/10/mic-141-10-2705.html?itemId=/content/journal/micro/10.1099/13500872-141-10-2705&mimeType=html&fmt=ahah

References

  1. Andersen P. 1994; Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins.. Infect Immun 62:2536–2544
    [Google Scholar]
  2. Bordier C. 1981; Phase separation of integral membrane proteins in Triton X-114 solution.. J Biol Chem 256:1604–1607
    [Google Scholar]
  3. Colditz G.A., Brewer T.F., Berkey C.S., Wilson M.E., Burdick E., Fineberg H.V., Mosteller F. 1994; Efficacy of BCG vaccine in the prevention of tuberculosis - meta analysis of the published literature.. J Am Med Assoc 271:698–702
    [Google Scholar]
  4. Collins M.E., Patki A., Wall S., Nolan A., Goodger J., Woodward M.J., Dale J.W. 1990; Cloning and characterization of the gene for the ‘19 kDa’ antigen of Mycobacterium bovis. . J Gen Microbiol 136:1429–1436
    [Google Scholar]
  5. Davies P.O.D. 1994; Infection with Mycobacterium kansasii. . Thorax 49:435–436
    [Google Scholar]
  6. Devereux J., Haerberli P., Smithies O. 1984; A comprehensive set of sequence analyses programs for the VAX.. Nucleic Acids Res 12:387–395
    [Google Scholar]
  7. Dooley S.D., Jarvis W.R., Martone W.J., Snider D.E. 1992; Multidrug-resistant tuberculosis.. Ann Intern Med 117:257–259
    [Google Scholar]
  8. Estrada I., Guitterez M., Esparza J., Quesada-Pascual F., Estrada-Parra S., Passani L. 1992; Use of synthetic peptides corresponding to sequences of Mycobacterium leprae to study delayed- type hypersensitivity responses in sensitized guinea pigs.. Int J Lepr 60:18–27
    [Google Scholar]
  9. Fikrig E., Barthold S.W., Marcantonio N., Deponte K., Kantor F. S., Flaveil R. 1992; Roles of ospA, ospB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice.. Infect Immun 60:657–661
    [Google Scholar]
  10. Fine P.E.M., Rodrigues L.C. 1990; Modern vaccines - mycobacterial diseases.. Lancet 335:1016–1020
    [Google Scholar]
  11. Finke M., Duchene M., Eckhardt A., Domdey H., Von Specht B.U. 1990; Protection against experimental Pseudomonas aeruginosa infection by recombinant P. aeruginosa lipoprotein I expressed in Escherichia coli. . Infect Immun 58:2241–2244
    [Google Scholar]
  12. Gelber R.H., Mehra V., Bloom B., Murray L.P., Sui P., Tsang M. 1994; Vaccination with pure Mycobacterium leprae inhibits M. leprae multiplication in mouse footpads.. Infect Immun 62:4250–4255
    [Google Scholar]
  13. Green B.A., Quinn-Dey T., Zlotnik G.W. 1987; Biologic activities of antibody to a peptidoglycan-associated lipoprotein of Haemophilus influenzae against multiple clinical isolates of H. influenzae type b.. Infect Immun 55:2878–2883
    [Google Scholar]
  14. Horsburgh C.R., Selik R. 1989; The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS).. Am Rev Respir Dis 139:4–7
    [Google Scholar]
  15. Horwitz M.A., Lee B.W.E., Dillon B.J., Harth G. 1995; Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. . Proc Natl Acad Sci, USA 921530–1534
    [Google Scholar]
  16. Kohler G., Milstein C. 1975; Continuous culture of fused cells secreting antibody of predetermined specificity.. Nature 256:495–497
    [Google Scholar]
  17. Levine B., Chaisson R.E. 1991; Mycobacterium kansasii-. a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection.. Ann Intern Med 114:861–868
    [Google Scholar]
  18. Lillo M., Orengo P., Cernoch P., Harris R.L. 1990; Pulmonary and disseminated infection due to Mycobacterium kansasii - a decade of experience.. Rev Infect Dis 12:760–767
    [Google Scholar]
  19. Mackall J.G, Bai G.H., Rouse D.A., Armoa G., Chuidian F., Nair J., Morris S.L. 1993; A comparison of the T cell delayed- type hypersensitivity epitopes of the 19 kD antigens from Mycobacterium tuberculosis and Mycobacterium intracellulare using synthetic peptides.. Clin Exp Immunol 93:172–177
    [Google Scholar]
  20. Morris S.L., Rouse D.A., Hussong D., Chaparas S.D. 1988; Isolation and characterization of a recombinant λgtl 1 bacteriophage which expresses an immunoreactive Mycobacterium intracellulare protein in Escherichia coli. . Infect Immun 56:3026–3031
    [Google Scholar]
  21. Morris S.L., Rouse D.A., Hussong D., Chaparas S.D. 1990; Isolation and characterization of recombinant λgtll bacteriophages expressing four different Mycobacterium intracellulare antigens.. Infect Immun 58:17–20
    [Google Scholar]
  22. Morris S.L., Bermudez L., Chaparas S.D. 1991; Mycobacterium avium complex disease in patients with AIDS: seroreactivity to native and recombinant mycobacterial antigens.. J Clin Microbiol 29:2715–2719
    [Google Scholar]
  23. Morris S.L, Nair J., Rouse D.A. 1992; The catalase-peroxidase of Mycobacterium intracellulare-, nucleotide sequence analysis and expression in Escherichia coli. . J Gen Microbiol 138:2363–2370
    [Google Scholar]
  24. Nair J., Rouse D.A., Morris S.L. 1992; Nucleotide sequence analysis and serologic characterization of the Mycobacterium intracellulre homologue of the Mycobacterium tuberculosis 19 kDa antigen.. Mol Microbiol 6:1431–1439
    [Google Scholar]
  25. Nair J., Rouse D.A., Morris S.L. 1993; Nucleotide sequence analysis and serologic characterization of a 27 kilodalton Myco-bacterium intracellulare lipoprotein.. Infect Immun 61:1074–1081
    [Google Scholar]
  26. Reilly L.W. 1993; Drug resistant tuberculosis.. Clin Infect Dis 17: suppl 2 S442–S446
    [Google Scholar]
  27. Rouse D.A., Morris S.L., Karpas A., Probst P.G., Chaparas S.D. 1990; Production, characterization, and species specificity of monoclonal antibodies to Mycobacterium avium complex protein antigens.. Infect Immun 58:1445–1449
    [Google Scholar]
  28. Shafer R.W., Sierra M.F. 1992; Mycobacterium xenopi, Mycobacterium fortuitum, Mycobacterium kansasii and other non-tuberculous mycobacteria in an area of endemicity for AIDS.. Clin Infect Dis 15:161–162
    [Google Scholar]
  29. Sheerer R., Sable R., Sonnenberg M., Cooper S., Spenser B., Schevimmer S., Kucha F., Muthuswamy P., Kallech C. 1986; Disseminated infection with Mycobacterium kansasii in the acquired immunodeficiency syndrome.. Ann Intern Med 105:710–712
    [Google Scholar]
  30. Shinnick T.M., Plikaytis B.B., Hyche A.D., Van Landinham R.M., Walker L.L. 1989; The Mycobacterium tuberculosis BCG A protein has homology with the Escherichia coli groES protein.. Nucleic Acids Res 17:1254
    [Google Scholar]
  31. Stover C.K., Bansal G.P., Hanson M.S., Burlein J.E., Palaszynski S.R., Young J.F., Koenig S., Young D.B., Sadziene A., Barbour A.G. 1993; Protective immunity elicited by recombinant Bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.. J Exp Med 178:197–209
    [Google Scholar]
  32. Studier F.W., Moffat B.W. 1986; Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.. J Mol Biol 189:113–130
    [Google Scholar]
  33. Vordermeier H.M., Harris D.P., Mehrota P.K., Roman E., Elsaghier A., Ivanyi J. 1992; M. tuberculosis complex specific T- cell stimulation and DTH reactions induced with a peptide from the 38 kDa protein.. Scand J Immunol 35:711–718
    [Google Scholar]
  34. Wallace R.J., O’Brien R., Glassroth J., Raleigh J., Dutt A. 1990; Diagnosis and treatment of disease caused by nontuberculous mycobacteria.. Am Rev Respir Dis 142:940–953
    [Google Scholar]
  35. Wu H.C., Tokunaga M. 1986; Biogenesis of lipoproteins in bacteria.. Curr Top Microbiol Immunol 125:127–157
    [Google Scholar]
  36. Young D.B., Garbe T.R. 1991; Lipoprotein antigens of Mycobacterium tuberculosis. . Res Microbiol 142:55–65
    [Google Scholar]
  37. Young L.S., Inderlied C.B., Berlin O.G., Gottlieb M.S. 1986; Mycobacterial infections in AIDS patients with an emphasis on the Mycobacterium avium complex.. Rev Infect Dis 8:1024–1033
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/13500872-141-10-2705
Loading
/content/journal/micro/10.1099/13500872-141-10-2705
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error